InvestorsHub Logo
Followers 63
Posts 9090
Boards Moderated 1
Alias Born 10/06/2003

Re: Illiana post# 25578

Tuesday, 06/23/2015 10:55:19 AM

Tuesday, June 23, 2015 10:55:19 AM

Post# of 97092
Unfortunately, the share price will likely continue to fall.

The J&J news is probably already built into the share price. You may seek a spike to a quarter or so (if you are lucky), but that is about it.

Think about it. All eggs are in one basket here. DECN talks about other business models/products, but I think that is just fluff. They didn't even bother to proofread the language for the "Discretion Messenger" product (see link below). Embarrassing, but par for the proverbial course here.http://www.pharmatechdirect.com/products.html

Let's not forget the negative financing issues here too. DECN is in bed with multiple hedge funds. Hedge funds that likely will short DECN, and can buy back to cover when profitable. A truly cake & eat it too scenario for the hedge funds. Further, the "special" deals for these hedge funds include below market DECN shares. Below market as in .00006/share in some cases. That's right, .00006/share. How nice for them, extremely dilutive for the small DECN shareholder like yourself.

Plus, I believe this DECN management is incompetent. They rarely communicate with the shareholder. A bad omen.

This is why I believe the DECN share price will continue to sink.